Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2022

View Archived Issues

CHIN-117 reduces inflammation in murine model of colitis

Researchers highlight use of NUAK2 inhibitor HTH-02-006 for treating prostate cancer

Eternity Bioscience patents new Raf kinase inhibitors

Athira Pharma discloses new HGFR modulators

Engineered CAR NK cells can be an effective therapy against SARS-CoV-2 infection

Lengo Therapeutics presents new EGFR and HER2 inhibitors

New NFE2L2 activators identified by Sitryx Therapeutics

Arena Pharmaceuticals synthesizes new 5-HT2A receptor antagonists

SA-FasL microgels induce immune acceptance of islet transplantation

Chemokine-targeting B7-H3.CAR-T cells show enhanced activity against NSCLC brain tumor lesions

Aging mice brains have slower protein turnover, linking aging to neurodegenerative disease

FDA awards orphan drug designation to TTI-101 for IPF

NHLBI grant supports IND-enabling studies of NMX-1 for triple-negative breast cancer

IMT-504 ameliorates neuropathic pain by modulating neuroimmune milieu

VeriSIM Life partners with Total Brain to support neurological drug development

Discovery of novel microtubule targeting agent for the treatment of cancer

Forma Therapeutics introduces USP1 inhibitor FT-3171

New myasthenia gravis rat model developed

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...